Through its platform, Amazon will offer access to treatments including Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. Pricing starts as low as $25 per month for insured patients, while oral drugs begin at $149 per month for cash-paying customers. Injectable treatments start at $299 per month without insurance.

The GLP-1 weight-loss category exploded into a multi-billion-dollar opportunity that blends medication access with ongoing patient support. This morning, Amazon‘s (NASDAQ:AMZN | AMZN Price Prediction) One Medical platform rolled out a national program that pairs GLP-1 prescriptions with primary care integration — regular check-ins,